Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Diagnostics and laboratory products / Clinical consumables and general diagnostics / Point-of-care and ambulatory-site collection consumables

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Point-of-care and ambulatory-site collection consumables

Single-use specimen-collection and handling consumables for testing performed outside the hospital core lab: swabs, lancets, capillary-collection and microtainer devices, urine/stool collection kits, and transport media used in physician practices, urgent-care, ambulatory surgery centres, and retail/occupational-health clinics. Excludes the point-of-care test kits and cartridges themselves.

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
65 /100
for B2B sellers
Evidence
not sized
1 source · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Physician practices, ambulatory surgery centres, urgent-care and retail clinics, occupational-health and school-health sites
Buying centre
Practice manager or clinic operations lead, with purchasing often via a physician-office distributor or a group purchasing organisation; infection-control nurse influence
Buying triggers
  • Shift of care into ambulatory and alternative care settings
  • Expansion of respiratory and syndromic panel testing in urgent care
  • Home and telehealth specimen collection programmes
  • Employer and school screening programmes
Pains
  • Low test volumes per site making premium consumable pricing hard to justify
  • Cold-chain and transport logistics for off-site samples
  • Needle-stick and infection-control exposure in high-throughput screening
  • Fragmented small-order purchasing with frequent stock-outs
Scores (1–5)
Pain intensity3
Purchasing power2
Reachability4
Growth4

How this was sized

Not sized yet

Bottom-up: worldwide laboratory diagnostics 2025 = USD 110.85bn [8]; hospital laboratories 49.3% [8], leaving USD 56.2bn for non-hospital-lab end users. This niche is a subset of that residual; applying a stated 5-8% consumables share of the non-hospital-lab pool gives roughly USD 2.8-4.5bn, i.e. USD 2,800-4,500m. Arithmetic: 110.85bn x 50.7% = 56.20bn; x 5-8% = 2.8-4.5bn. Confidence Low: the 5-8% share is an assumption and the residual pool includes reference labs and diagnostic centres, so this figure is an upper-leaning estimate of the ambulatory slice.

Sources

Alongside it in Clinical consumables and general diagnostics

// Sell into Point-of-care and ambulatory-site collection consumables

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.